In the Journal of Integrative and Complementary Medicine, Nova Scholar Richard Hammerschlag and co-authors assess the current research landscape of biofield therapies through the first comprehensive scoping review of peer-reviewed clinical studies on biofield therapies up to January 2024. This review can be used to explore potential research directions based on gaps and promising areas of exploration.
This scoping review maps the research landscape, analyzing 353 studies that met author-defined eligibility criteria. Challenges in biofield therapies (BT) research include inconsistent reporting of practitioner qualifications, therapy dosage, and intervention details, making it difficult to evaluate effectiveness. A new evidence map was developed to help researchers and policymakers navigate BT studies. However, limitations include a focus on English-language studies, lack of bias assessment, and exclusion of preclinical research. Addressing these gaps is crucial for validating BTs and integrating them into mainstream health care. By coordinating all evidence through the evidence map, stakeholders are equipped to learn about BT research, find ways to address the challenges hindering BT acceptance, and carry out further research to validate whether BTs are appropriate supplemental interventions in contemporary allopathic health care.





